Latest Capital Efficiency News

Amaero Ltd has reported a remarkable 366% increase in revenue for the first half of FY2026, alongside key capital investments and formal validation from the US Navy, signalling a strong move towards scaled commercial production.

Eminence Minerals has appointed Anthony Hills as CEO, bringing over 16 years of global operational expertise to accelerate its exploration and project development efforts.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

AdAlta Limited has raised A$1.2 million through a strategic placement to advance its innovative PD1 armored MSLN CAR-T therapy for solid cancers, reinforcing its unique 'East to West' cellular immunotherapy approach.

Tamboran Resources has appointed Todd Abbott as CEO, bringing over 25 years of upstream oil and gas expertise to lead its pivotal Beetaloo Basin development.

High-Tech Metals has signed a non-binding MoU with Wiluna Mining to assess toll treatment options for ore from its Mt Fisher and Mt Eureka projects, aiming to leverage existing processing infrastructure for capital-efficient development.

Meteoric Resources has received a conditional Letter of Support from Export Finance Australia for up to US$50 million to advance its Caldeira Rare Earth Project in Brazil, complementing prior US financing interest and reinforcing Australia-Brazil supply chain ties.

Bayan Mining has appointed Nathan Kong as its new CEO, bringing over 17 years of tier-one mining experience to lead its rare earth projects and strategic growth initiatives.

IAG has integrated RACQ Insurance into its core reinsurance programs, expanding catastrophe coverage and boosting downside protection through to 2029. This move aims to stabilise earnings and unlock synergies following RACQ’s acquisition.

AdAlta Limited and its subsidiary AdCella have partnered with Shanghai Cell Therapy Group to co-develop a pioneering CAR-T cancer therapy targeting solid tumours outside China. This collaboration aims to bring a novel, armored immunotherapy with promising clinical results to global markets.

Argo Investments Limited has announced the renewal of its on-market buy-back facility, allowing the company to repurchase up to 37 million ordinary shares throughout 2026 as part of its capital management strategy.

Medallion Metals secures ASX waiver allowing its discounted Share Purchase Plan to proceed without shareholder approval, enabling retail investors to buy shares at the same price as institutions.